Search clinical trials for: Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b
Total 224 results
-
Teva Neuroscience, Inc.Completed
-
Nancy Hammond, MDKansas City Area Life Sciences Institute, Inc.CompletedMultiple Sclerosis | Low Bone DensityUnited States
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-Remitting
-
BiogenWithdrawnRelapsing Multiple Sclerosis
-
BiogenCompletedRelapsing-Remitting Multiple Sclerosis (RRMS)Italy
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States, Italy, Switzerland, Canada, Australia, Germany, Spain, France, Portugal, Netherlands, United Kingdom, Denmark, Austria, Ireland
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Croatia, Russian Federation, India, Spain, New Zealand, Canada, Belgium, Netherlands, Bulgaria, Serbia, Greece, Ukraine, Mexico, Georgia, Colombia, Germany, Poland, United Kingdom, Czech Republic, France, Chile, Romania, Eston... and more
-
BiogenCompletedRelapsing Remitting Multiple SclerosisPortugal
-
Fred LublinNational Institute of Neurological Disorders and Stroke (NINDS)CompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Germany, Russian Federation, India, New Zealand, Spain, Belgium, Colombia, Canada, Bulgaria, Serbia, Greece, Peru, Ukraine, Poland, United Kingdom, Croatia, France, Romania, Chile, Czech Republic, Mexico, Estonia, Georgia, Latv... and more
-
BiogenAMS Advanced Medical Services GmbHCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Johns Hopkins UniversityBiogenWithdrawn
-
BayerNovartis Pharmaceuticals; Biogen; EPID Research; Merck Serono Europe LtdCompleted
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing Remitting Multiple Sclerosis
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
EMD SeronoPfizerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)United States
-
Trio Medicines Ltd.BiogenCompleted
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
Beth Israel Deaconess Medical CenterBiogenCompletedMultiple Sclerosis | Optic Neuritis | Transverse Myelitis | Acute Brainstem/Cerebellar SyndromeUnited States, Canada
-
Bosnalijek D.DMonitorCRORecruitingMultiple Sclerosis, Relapsing-RemittingTurkey
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis (RRMS)
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisRussian Federation
-
CelgeneCompletedMultiple SclerosisUnited States, Spain, Czechia, Russian Federation, Portugal, Serbia, United Kingdom, New Zealand, Belarus, Bulgaria, Poland, Romania, Estonia, Germany, Sweden, Ukraine, Hungary, Croatia, Georgia, Bosnia and Herzegovina, Latvia, Li... and more
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.P.A., ItalyCompleted
-
NeurognosticsTerminatedRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompleted
-
BiogenCompletedMultiple SclerosisUnited States
-
Melinda MagyariUniversity of CopenhagenCompleted
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, Israel, Sweden, United States, France, Switzerland, Ireland, Canada, Australia, Brazil, Austria, Poland, Germany, Hungary, Netherlands, Russian Federation, Spain, Argentina, Slovenia, Greece, Finland, Denmark, Ukraine, Italy, L... and more
-
BiogenWithdrawn
-
Shahid Beheshti University of Medical SciencesCompleted
-
EMD Serono Research & Development Institute, Inc.CompletedMultiple SclerosisUnited States, Italy, Russian Federation, Spain
-
Mitsubishi Tanabe Pharma CorporationToray Industries, IncCompleted
-
Novartis PharmaceuticalsRecruitingMultiple SclerosisGermany, Spain, Italy, France, United Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingHepatocellular Carcinoma | Advanced Malignant Solid NeoplasmUnited States
-
BayerBiogen Netherlands B.V; Novartis Europharm Limited; Merck Europe B.V.Not yet recruitingMultiple Sclerosis (MS)Sweden, Finland
-
University of Medicine and Dentistry of New JerseyCompletedMultiple SclerosisUnited States
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Spain
-
Faron Pharmaceuticals LtdCompletedAcute Respiratory Distress Syndrome | Acute Lung InjuryUnited Kingdom
-
Faron Pharmaceuticals LtdTerminated
-
BiogenRecruitingMultiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing Remitting Multiple Sclerosis
-
SanofiCompletedMultiple SclerosisUnited States, Canada, Germany, Italy, Spain, United Kingdom, Austria
-
Merck KGaA, Darmstadt, GermanyTerminatedMultiple Sclerosis, Relapsing-RemittingItaly
-
Brigham and Women's HospitalEMD SeronoWithdrawnMultiple SclerosisUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Metastatic Uveal Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Pathologic Stage III Cutaneous... and other conditionsUnited States
-
Eli Lilly and CompanyCompletedAlzheimer's DiseaseUnited States, Argentina, Brazil, Japan, Canada
-
Eli Lilly and CompanyCompletedAlzheimer's DiseaseSpain, United States, France, Korea, Republic of, Japan, Australia, Taiwan, Sweden, Germany, Italy, Poland, Russian Federation, United Kingdom
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)Completed